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existing needle geometry was used to regenerate new 
treatment plans for three radiation schemes: 1x19.0Gy, 
1x19.5Gy and 1x20Gy. All plans were optimized according to 
the following objectives: 
Prostate V100% ≥ 95% Prostate D90% ≥ 100% 
Bladder D1cc < 16.0 Gy Bladder D2cc < 15.5 Gy  
Rectum D1cc < 15.5 Gy Rectum D2cc < 14.5 Gy Rectum V100% 
0 cc 
Urethra D0,1cc < 21.0 Gy Urethra D10% < 20.5 Gy Urethra 
V120% 0 cc 
A total of 90 plans were generated using an inverse planning 
module. The planning target volume (PTV) was the prostate 
without margins. The coverage of the prostate was 
maximized considering the dose constraints for the organs at 
risk (OAR). The primary end point of this study was the 
feasibility of above mentioned target coverage and OAR 
constraints. The secondary end point was to investigate the 
restricting factors to reach a feasible plan stratified to 
prostate volume, OAR position and implant geometry. 
 
Results: The average prostate V100% for the 19.0, 19.5 and 
20.0Gy schemes was 96.6%, 95.3% and 93.0% respectively 
with 83%, 57% and 33% of plans meeting this objective. The 
D90% of the prostate averaged 20.3 Gy , 20.3 Gy and 20.4 Gy 
respectively. Only 4 plans failed this objective. 
The 40-70cc group showed an average prostate V100% of 
96.3% an increase of 2.1% and 2.7% compared to the < 40cc 
and >70cc group respectively.  
The number of needles had no influence on prostate coverage 
and urethra constraints. The rectum and bladder D1cc and 
D2cc increased for the 17-22 needle group with 5.7%, 8.6% 
and 3.3%, 5.3% respectively.  
The average prostate V100% decreased in patients with a 
larger distance between the urethra and the posterior border 
of the prostate. 
Prostate V100% increased from 95.7% to 97.5% in patients 
with a prostate to rectum distance of 2mm or more. 
 
Conclusion: Single fraction HDR brachytherapy as 
monotherapy in patients with prostate cancer is feasible 
using our current implant geometry. Considering the OAR 
constraints, an acceptable D90% was reached in 96% of 
plans.Prostate volume, implant geometry and OAR proximity 
have a substantial impact on target coverage. 
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Purpose or Objective: To evaluate the feasibility of 
automated single arc treatment planning for prostate cancer 
patients using a commercially available treatment planning 
system. We also compared the resultant AutoplanningTM 
plans with our current institutional inverse planned 
prostates. 
 
Material and Methods: A technique was created within the 
AutoplanningTM module of the PinnacleTM treatment 
planning system using institutional prescription 
dose/fractionation and OAR constraints to be delivered with 
a single arc VMAT plan. The Planning Target Volume PTV1 
(74Gy) encompasses the prostate; PTV2 (66.6Gy) 
encompasses the prostate and the base or full seminal 
vesicles plus setup margins both delivered simultaneously in 
37 fractions. Plans were generated for 10 randomly selected 
patients with prostate cancer treated at our institution, using 
the automated treatment technique template. Plan quality 
was assessed using institutional criteria and ICRU 83 criteria: 
D98, D2, Conformity Index (CI), Homogeneity Index (HI) and 
Remaining Volume at Risk (RVR). OAR constraints for rectum 
D65<30%, Bladder D50<50%, Femoral Heads, D50< 50%. Bowel 
D50<50cc, D55<14cc and D60< 1cc were assessed. The time 
for planning was also documented. 
The ten AutoplanningTM technique plans were compared with 
clinical institutional VMAT prostate plans in a blinded study. 
Plans were compared by Clinical Oncologists, assessing 
clinical coverage of the PTVs, OAR sparing and DVH 
parameters. 
 
Results: Table 1 summarises results of the automated plan 
generation. The automated technique produced highly 
conformal plans that met institutional clinical constraints for 
7 of 10 plans in a single run. In the 3 cases that failed, 
overlap of the PTV with rectum or bowel exceeded 
institutional DVH goals (Fig 1). There were no significant 
differences between the two planning techniques when 
comparing CI and HI. 
 
Table 1 Dosimetric Results for PTV and OAR with Automated 
Planning Technique 
 
 
Fig 1. Impact of PTV overlap on Mean OAR doses for 
automated planning technique. 
 
Conclusion: The automated technique for VMAT planning for 
prostate cancer is a promising solution which is feasible and 
may improve efficiency by automating cases that meet 
institutional dose volume constraints. We will present the 
results of the blinded plan selection study at the meeting.  
 
OC-0559  
The impact of rectal interventions on target motion and 
rectal variability in prostate radiotherapy 
C. Smith1, B. O'Neill2, L. O'Sullivan2, M. Keaveney2, L. 
Mullaney1 
ESTRO 35 2016                                                                                                                                                    S269 
______________________________________________________________________________________________________ 
1Discipline of Radiation Therapy- School of Medicine- Trinity 
Centre Dublin, Radiation Therapy, Dublin, Ireland Republic 
of 
2St Luke's Radiation Oncology Network- Beaumont Hospital, 
Radiation Therapy Department, Dublin, Ireland Republic of 
 
Purpose or Objective: Target position is variable during 
fractionated prostate radiotherapy, mainly due to rectal 
changes. Margin reduction is preferable with the 
advancements of modulated techniques and IGRT. However, 
geometric uncertainty can persist in the absence of an 
intervention to minimise rectal motion. The purpose of this 
study is to retrospectively evaluate the effectiveness of three 
rectal emptying strategies in maintain rectal stability and 
reducing target motion during prostate radiotherapy. 
 
Material and Methods: Four cohorts of consented prostate 
patients (total n=37) underwent different rectal strategies: 
daily phosphate enema; low-fibre diet and microlax 
microenema and no intervention (control). Using 
retrospective CBCT data, (8 CBCTs per patients), inter-
fraction PTV motion relative to bony anatomy was measured 
using automatic bone anatomy registration, followed by an 
automatic Structure Volume of Interest (SVOI) match. 
Changes in rectal diameter (RD) at the base, mid and apex of 
the prostate and rectal volume (RV) were measured using the 
CBCT data. Frequency of prostate geometric miss was 
assessed, with a miss defined as any PTV shift in any 
direction. 
 
Results: PTV displacement was significantly reduced in the 
anteroposterior (AP) direction in the microlax group 
(p=0.004), and in the superoinferior (SI) direction in the 
phosphate enema group (p=0.013) when compared with the 
control group (Table 1). The frequency of geometric miss was 
lowest in the microlax group. RD variability at the base of 
prostate was significantly smaller in the microlax and 
phosphate enema groups compared to the control group 
stats, and variation in RV was smallest in the microlax group. 
PTV motion and rectal variability were largest in the control 
group. 
 
 
Conclusion: Microlax microenema is an effective intervention 
in maintaining rectal stability, and PTV motion during 
prostate radiotherapy, in patients with large RD (≥4cm) on 
planning CT. 
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Purpose or Objective: Our primary aim is to investigate the 
frequency of using smaller margins for post prostatectomy 
radiotherapy (RT) in conjunction with daily soft tissue image 
guided radiotherapy (IGRT). Our secondary aim is to assess 
the feasibility of implementing an adaptive, ‘plan of the 
day’, treatment approach by selecting an appropriate plan on 
a daily basis which will highly conform to the target and 
minimise rectal and bladder toxicities. 
 
Material and Methods: Retrospectively identified 19 post 
prostatectomy patients. Soft tissue matching guidelines were 
created and split into two categories; patients with or 
without surgical clips. Soft tissue match was performed on 
cone-beam CT (CBCT) in offline review program by two 
radiation therapists and reviewed by two radiation 
oncologists. The frequency of geographic miss was measured 
using a planning target volume (PTV) small with a 5 mm 
clinical target volume (CTV) expansion and PTV large with 10 
mm (15 mm anteriorly) CTV expansion. To implement a ‘plan 
of the day’ treatment approach, a post prostatectomy soft 
tissue training module was developed to educate the 
radiation therapists to perform daily soft tissue alignment. 
Radiation therapists will then apply an adaptive RT regime 
that selects from a plan library to account for internal organ 
inconsistencies of the bladder and rectum. 
 
Results: A total of 135 CBCTs were reviewed on 19 radical 
post prostatectomy patients including those with lymph node 
involvement. Retrospective soft tissue match analysis 
determined that PTV small covered the target for 84% of 
CBCTs while the PTV large covered the target for 16%. There 
was no geographic miss outside PTV large in this 
retrospective analysis. In the matches that resulted in the 
selection of PTV large, 12% of CBCTs were due to variations 
in bladder filling and 4% from rectal filling. 
 
Conclusion: PTV small is suitable for use on most CBCTs with 
PTV large selected for only a small portion of CBCTs. Very 
small bladders caused a greater amount of bladder and small 
bowel to fall in the target and increases the chance of side 
effects but rarely causes a geographic miss. Over filling 
bladders on CBCTs was undesired as it caused internal pelvic 
tilt in the superior portion resulting in a selection of the plan 
with PTV large. A dangerous combination is present if there 
are inconsistencies to both the bladder and rectum filling 
causing the CTV prostate bed region to tilt and fall outside of 
the target. With a high frequency of using PTV small, and a 
better understanding of the effect of bowel and bladder 
filling, implementation of ‘plan of the day’ is feasible. This 
will result in a highly targeted treatment delivery in 
conjunction with soft tissue IGRT that will reduce toxicities 
and increase local control. 
 
Poster Viewing : 12: Physics: Dose measurement and dose 
calculation III  
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Purpose or Objective: Low energy X-rays Intra-Operative 
Radiation Therapy (XIORT) is increasingly used in oncology, 
predominantly for breast cancer treatments with spherical 
applicators [1], but also for skin or gastrointestinal cancer [2] 
with surface and flat applicators. This study aims to validate 
a fast and precise method [3,4] to calculate Monte Carlo (MC) 
dose distributions with an optimized phase space file (PSF) 
obtained from a previously stored database of 
monochromatic PSF and depth dose curves (DDP) for different 
INTRABEAM® (Carl Zeiss) applicators. To validate this 
procedure, we compared dose computed with the PSF with 
measurements in phantoms designed to prove actual XIORT 
scenarios. 
 
Material and Methods: PSF were optimized from 
experimental DDP in water and were employed to calculate 
dose distributions, first in water, then in validation phantoms 
